Results 271 to 280 of about 37,646,315 (377)

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

De-implementation of low-value home-based nursing care: an effect and process evaluation. [PDF]

Implement Sci Commun
Cremers M, Schoonhoven L, van Bodegom-Vos L, Bleijenberg N, Witsiers C, van Dijk M, Ista E.   +6 more
europepmc   +1 more source

Initial evaluation of dry storage issues for spent nuclear fuels in wet storage at the Idaho Chemical Processing Plant

, 1996
R Guenther, A.B. Johnson, Anders Lund, Erin Gilbert   +3 more
openalex   +2 more sources

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

Process Evaluation of a Rapid Evidence Support System Assessment of Ireland's Department of Health - A Protocol. [PDF]

HRB Open Res
Tierney M, Whelan B, Burke NN, Creely C, Duffy T, Gill C, Horgan M, Lavis JN, Maguire T, O'Driscoll M, O'Neill J, Toomey E, Waddell K, Devane D.   +13 more
europepmc   +1 more source

Developing and Evaluating the (LUCID/Star)*Usability Engineering Process Model

, 2001
James W. Helms
openalex   +1 more source

Controlled comparison of advanced froth flotation process technology and economic evaluations for maximizing BTU recovery and pyritic sulfur rejection

, 1990
K.E. Harrison, D.D. Ferris, R.M. Kosky, J.J. Warchol, W.F. Musiol, S.Y. Shiao, G.H. Luttrell, G.T. Adel, Roe‐Hoan Yoon   +8 more
openalex   +2 more sources

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

Molecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard, Sarmad Mehmood, Eva Boysen Fynboe Ebert, Peter Meldgaard, Anindya Dutta, Boe S. Sorensen   +5 more
wiley   +1 more source